New Zealand markets closed

Seres Therapeutics, Inc. (MCRB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
6.23+0.13 (+2.13%)
At close: 4:00PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts7769
Avg. Estimate-0.46-0.48-1.86-1.37
Low estimate-0.54-0.55-2-2.48
High estimate-0.4-0.41-1.731.18
Year ago EPS-0.36-0.23-1.12-1.86
Revenue estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts7768
Avg. Estimate7.32M6.93M25.57M102.07M
Low estimate5M1.96M20.98M20M
High estimate12.18M12.18M35.34M348.3M
Year ago salesN/A17.56M33.22M25.57M
Sales growth (year/est)N/A-60.50%-23.00%299.20%
Earnings history29/09/202030/12/202030/03/202129/06/2021
Est. EPS-0.25-0.28-0.31-0.37
Actual EPS-0.36-0.23-0.39-0.53
Difference-0.110.05-0.08-0.16
Surprise %-44.00%17.90%-25.80%-43.20%
EPS trendCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Current estimate-0.46-0.48-1.86-1.37
7 days ago-0.46-0.48-1.86-1.37
30 days ago-0.46-0.48-1.86-1.36
60 days ago-0.46-0.48-1.86-1.36
90 days ago-0.35-0.33-1.43-1.11
EPS revisionsCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesMCRBIndustrySector(s)S&P 500
Current qtr.-27.80%N/AN/AN/A
Next qtr.-108.70%N/AN/AN/A
Current year-66.10%N/AN/AN/A
Next year26.30%N/AN/AN/A
Next 5 years (per annum)-134.00%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A